title: Immunogenicity and protective efficacy of recombinant Campylobacter jejuni flagellum-secreted proteins in mice.
abstract: Immunogenicity and protective efficacy of three Campylobacter jejuni flagellum-secreted proteins, FlaC, FspA1, and FspA2, were compared by use of a mouse model. Mice were immunized intranasally with each protein with or without LTR192G as the adjuvant and challenged intranasally with C. jejuni 81-176 or CG8486. All three proteins were immunogenic, although FspA1 induced the highest levels of serum immunoglobulin G (IgG) and fecal IgA. Although immunogenic, FlaC provided only 18% protection against disease from C. jejuni 81-176. Immunization with FspA1 resulted in 57.8% protection without adjuvant or 63.8% protection with adjuvant against homologous challenge with 81-176. Alternatively, immunization with FspA2 provided 38.4% (without adjuvant) or 47.2% (with adjuvant) protection against disease from homologous challenge with CG8486. In contrast to FspA2, FspA1 provided some heterologous protection against C. jejuni CG8486 when delivered with (31.2%) or without (44.8%) LTR192G. These results suggest that FspA1 may be a good subunit vaccine candidate against C. jejuni disease.
authors.affiliation: Enteric Diseases Department, Naval Medical Research Center, 503 Robert Grant Avenue, Silver Spring, MD 20910-7500, USA. shahida.baqar@med.navy.mil
authors.forename: Shahida
authors.initials: S
authors.lastname: Baqar
authors.forename: Lisa A
authors.initials: LA
authors.lastname: Applebee
authors.forename: Theron C
authors.initials: TC
authors.lastname: Gilliland
authors.forename: Lanfong H
authors.initials: LH
authors.lastname: Lee
authors.forename: Chad K
authors.initials: CK
authors.lastname: Porter
authors.forename: Patricia
authors.initials: P
authors.lastname: Guerry
mesh_terms: D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood; D001426:Bacterial Proteins / Q000235:genetics / Q000276:immunology* / Q000302:isolation & purification / Q000378:metabolism; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology*; D002169:Campylobacter Infections / Q000382:microbiology / Q000517:prevention & control*; D016123:Campylobacter jejuni / Q000235:genetics / Q000276:immunology / Q000378:metabolism / Q000472:pathogenicity*; D005260:Female; D005407:Flagella / Q000378:metabolism*; D005408:Flagellin / Q000235:genetics / Q000276:immunology* / Q000302:isolation & purification / Q000378:metabolism; D051379:Mice; D008807:Mice, Inbred BALB C; D011994:Recombinant Proteins / Q000235:genetics / Q000276:immunology* / Q000302:isolation & purification / Q000378:metabolism; D014611:Vaccination
chemical_list: D000907:Antibodies, Bacterial; D001426:Bacterial Proteins; D001428:Bacterial Vaccines; D011994:Recombinant Proteins; D005408:Flagellin